Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement
June 15, 2016 07:30 ET
|
Carbylan Therapeutics
--Transaction forms combined NASDAQ-listed biopharmaceutical company, focused on the discovery, development and commercialization of plasma kallikrein inhibitors for the treatment of hereditary...
Carbylan Therapeutics Announces Decision to Pursue Strategic Transaction
April 15, 2016 07:30 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., April 15, 2016 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company, announced today that it has suspended further clinical development of...
Carbylan Therapeutics Engages Wedbush PacGrow to Advise on Strategic Alternatives
March 17, 2016 16:15 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., March 17, 2016 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination...
Carbylan Therapeutics Reports Top-Line Results From COR1.1 Clinical Trial of Hydros-TA in Patients With OA of the Knee
February 01, 2016 16:01 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination...
Carbylan Therapeutics Announces Third Quarter 2015 Financial Results
November 11, 2015 07:30 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination therapies,...
Carbylan Therapeutics Schedules Third Quarter 2015 Financial Results
November 04, 2015 08:30 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination therapies,...
Carbylan Therapeutics Reports Employment Inducement Award to John McKune
November 03, 2015 16:15 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination therapies,...
Carbylan Therapeutics Announces Second Quarter 2015 Financial Results
August 11, 2015 16:01 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Carbylan® Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination...
Carbylan Therapeutics Reports Employment Inducement Award to Dr. Prem Ramiya
August 05, 2015 16:15 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination therapies,...
Carbylan Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
August 05, 2015 08:30 ET
|
Carbylan Therapeutics
PALO ALTO, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination therapies,...